Canada Life’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,404
Closed -$127K 2185
2023
Q3
$127K Sell
11,404
-16,605
-59% -$185K ﹤0.01% 1920
2023
Q2
$600K Sell
28,009
-1,176
-4% -$25.2K ﹤0.01% 1644
2023
Q1
$1.18M Sell
29,185
-1,079
-4% -$43.6K ﹤0.01% 1449
2022
Q4
$1.41M Buy
30,264
+6,691
+28% +$312K ﹤0.01% 1399
2022
Q3
$1.22M Buy
23,573
+5,539
+31% +$287K ﹤0.01% 1402
2022
Q2
$853K Buy
18,034
+2,211
+14% +$105K ﹤0.01% 1524
2022
Q1
$1.16M Buy
15,823
+17
+0.1% +$1.24K ﹤0.01% 1477
2021
Q4
$1.18M Buy
15,806
+92
+0.6% +$6.88K ﹤0.01% 1458
2021
Q3
$896K Hold
15,714
﹤0.01% 1561
2021
Q2
$692K Buy
15,714
+33
+0.2% +$1.45K ﹤0.01% 1658
2021
Q1
$769K Sell
15,681
-1,636
-9% -$80.2K ﹤0.01% 1608
2020
Q4
$729K Sell
17,317
-2,437
-12% -$103K ﹤0.01% 1636
2020
Q3
$904K Sell
19,754
-365
-2% -$16.7K ﹤0.01% 1449
2020
Q2
$1.01M Sell
20,119
-279
-1% -$14K ﹤0.01% 1439
2020
Q1
$1.05M Buy
20,398
+911
+5% +$46.7K ﹤0.01% 1268
2019
Q4
$1.19M Buy
+19,487
New +$1.19M ﹤0.01% 1404
2019
Q3
Sell
-20,952
Closed -$1.77M 1465
2019
Q2
$1.77M Buy
20,952
+124
+0.6% +$10.5K ﹤0.01% 1248
2019
Q1
$1.99M Buy
20,828
+719
+4% +$68.7K 0.01% 1054
2018
Q4
$1.31M Buy
20,109
+1,657
+9% +$108K ﹤0.01% 1267
2018
Q3
$1.58M Hold
18,452
﹤0.01% 1318
2018
Q2
$2.14M Sell
18,452
-165
-0.9% -$19.1K 0.01% 1133
2018
Q1
$1.51M Sell
18,617
-1,218
-6% -$98.5K ﹤0.01% 1321
2017
Q4
$1.16M Sell
19,835
-1,956
-9% -$115K ﹤0.01% 1474
2017
Q3
$1M Buy
21,791
+3,006
+16% +$138K ﹤0.01% 1518
2017
Q2
$676K Hold
18,785
﹤0.01% 1633
2017
Q1
$579K Buy
18,785
+1,600
+9% +$49.3K ﹤0.01% 1674
2016
Q4
$576K Hold
17,185
﹤0.01% 1662
2016
Q3
$457K Buy
17,185
+1,068
+7% +$28.4K ﹤0.01% 1688
2016
Q2
$355K Buy
+16,117
New +$355K ﹤0.01% 1727